Growth Metrics

Amneal Pharmaceuticals (AMRX) Goodwill & Intangibles (2017 - 2025)

Amneal Pharmaceuticals (AMRX) has 9 years of Goodwill & Intangibles data on record, last reported at $587.9 million in Q3 2025.

  • For Q3 2025, Goodwill & Intangibles changed N/A year-over-year to $587.9 million; the TTM value through Sep 2025 reached $587.9 million, changed N/A, while the annual FY2024 figure was $1.3 billion, 122.14% up from the prior year.
  • Goodwill & Intangibles reached $587.9 million in Q3 2025 per AMRX's latest filing, down from $597.4 million in the prior quarter.
  • Across five years, Goodwill & Intangibles topped out at $1.3 billion in Q4 2024 and bottomed at $587.9 million in Q3 2025.
  • Average Goodwill & Intangibles over 5 years is $740.1 million, with a median of $598.6 million recorded in 2023.
  • Peak YoY movement for Goodwill & Intangibles: crashed 67.55% in 2021, then surged 122.14% in 2024.
  • A 5-year view of Goodwill & Intangibles shows it stood at $593.0 million in 2021, then rose by 0.98% to $598.9 million in 2022, then fell by 0.04% to $598.6 million in 2023, then soared by 122.14% to $1.3 billion in 2024, then plummeted by 55.79% to $587.9 million in 2025.
  • Per Business Quant database, its latest 3 readings for Goodwill & Intangibles were $587.9 million in Q3 2025, $597.4 million in Q2 2025, and $597.5 million in Q1 2025.